WO2009151256A3 - 클로피도크렐 및 그의 유도체의 제조방법 - Google Patents
클로피도크렐 및 그의 유도체의 제조방법 Download PDFInfo
- Publication number
- WO2009151256A3 WO2009151256A3 PCT/KR2009/003083 KR2009003083W WO2009151256A3 WO 2009151256 A3 WO2009151256 A3 WO 2009151256A3 KR 2009003083 W KR2009003083 W KR 2009003083W WO 2009151256 A3 WO2009151256 A3 WO 2009151256A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivatives
- clopidogrel
- present
- active
- enzyme
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010154156/04A RU2469039C2 (ru) | 2008-06-09 | 2009-06-09 | Способ получения клопидогреля и его производных |
JP2011512392A JP2011522535A (ja) | 2008-06-09 | 2009-06-09 | クロピドグレル及びその誘導体の製造方法 |
CN2009801215031A CN102056931A (zh) | 2008-06-09 | 2009-06-09 | 氯吡格雷及其衍生物的制备方法 |
US12/996,733 US20110087028A1 (en) | 2008-06-09 | 2009-06-09 | Method for preparing clopidogrel and its derivatives |
EP09762643A EP2298777A4 (en) | 2008-06-09 | 2009-06-09 | PROCESS FOR THE PREPARATION OF CLOPIDOGREL AND ITS DERIVATIVES |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080053815A KR100990949B1 (ko) | 2008-06-09 | 2008-06-09 | 클로피도그렐 및 그의 유도체의 제조방법 |
KR10-2008-0053815 | 2008-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009151256A2 WO2009151256A2 (ko) | 2009-12-17 |
WO2009151256A3 true WO2009151256A3 (ko) | 2010-03-18 |
Family
ID=41417234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/003083 WO2009151256A2 (ko) | 2008-06-09 | 2009-06-09 | 클로피도크렐 및 그의 유도체의 제조방법 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110087028A1 (ko) |
EP (1) | EP2298777A4 (ko) |
JP (1) | JP2011522535A (ko) |
KR (1) | KR100990949B1 (ko) |
CN (1) | CN102056931A (ko) |
RU (1) | RU2469039C2 (ko) |
WO (1) | WO2009151256A2 (ko) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
CN102391283B (zh) * | 2011-09-20 | 2012-11-21 | 海南灵康制药有限公司 | 一种硫酸氢氯吡格雷化合物及其制法 |
CA2873094A1 (en) * | 2012-05-07 | 2013-11-14 | Cellixbio Private Limited | Prodrugs of anti-platelet agents |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
JP2015519333A (ja) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 神経疾患の治療のための組成物および方法 |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
CN104583182A (zh) | 2012-05-23 | 2015-04-29 | 塞利克斯比奥私人有限公司 | 用于治疗粘膜炎的组合物和方法 |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
CN104603097A (zh) | 2012-05-23 | 2015-05-06 | 塞利克斯比奥私人有限公司 | 用于治疗多发性硬化症的组合物和方法 |
CA2873096A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014195961A1 (en) | 2013-06-04 | 2014-12-11 | Mahesh Kandula | Compositions and methods for the treatment of diabetes and pre-diabetes |
CN103412064B (zh) * | 2013-07-25 | 2015-05-20 | 苏州立新制药有限公司 | 通过高效液相色谱检测邻氯苯甘氨酸杂质的方法 |
CN103467486B (zh) * | 2013-09-10 | 2016-04-13 | 宁夏康亚药业有限公司 | 一种氯吡格雷硫酸氢盐复合物的制备方法 |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CN105272993A (zh) * | 2014-07-03 | 2016-01-27 | 重庆安格龙翔医药科技有限公司 | 一种制备普拉格雷中间体的方法 |
CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
ES2799309T3 (es) | 2014-09-29 | 2020-12-16 | Cellix Bio Private Ltd | Compuestos y composiciones para el tratamiento de esclerosis múltiple |
CN104293875B (zh) * | 2014-10-11 | 2017-07-07 | 宁夏大学 | 生物酶催化制备(s)‑2‑氯苯甘氨酸甲酯单一对映体的方法 |
CA2965449C (en) | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
CN107428697A (zh) | 2015-01-06 | 2017-12-01 | 塞尔利克斯生物私人有限公司 | 用于治疗炎症和疼痛的组合物和方法 |
CN110283089A (zh) * | 2019-06-12 | 2019-09-27 | 苏州岚云医药科技有限公司 | 一种抗癌药物甘氨酸甲脂的合成工艺 |
CN111607631B (zh) * | 2020-07-06 | 2022-09-30 | 浙江工业大学 | 一种(s)-邻氯苯甘氨酸甲酯酶法合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495691B1 (en) * | 2001-07-06 | 2002-12-17 | Brantford Chemicals Inc. | Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
US20040176637A1 (en) * | 2003-03-03 | 2004-09-09 | Robert C. C. Wu | Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation |
US20070225320A1 (en) * | 2006-03-27 | 2007-09-27 | Eswaraiah Sajja | Process for preparing clopidogrel |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2652575B1 (fr) * | 1989-09-29 | 1992-01-24 | Sanofi Sa | Procede de preparation d'acides alpha-bromo phenylacetiques. |
US5189170A (en) | 1989-09-29 | 1993-02-23 | Sanofi | Process for the preparation of phenylacetic derivatives of thieno-pyridines |
FR2664596B1 (fr) * | 1990-07-10 | 1994-06-10 | Sanofi Sa | Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese. |
FR2760456B1 (fr) | 1997-03-05 | 2000-05-12 | Sanofi Sa | Procede de preparation de derives de 2-thienyl-ethylamine |
HU222283B1 (hu) | 1997-05-13 | 2003-05-28 | Sanofi-Synthelabo | Eljárás tieno[3,2-c]piridin-származékok előállítására |
FR2769313B1 (fr) | 1997-10-06 | 2000-04-21 | Sanofi Sa | Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese |
CN100338068C (zh) * | 2001-01-24 | 2007-09-19 | 卡地拉健康护理有限公司 | 制备氯吡格雷的方法 |
EP1606231A1 (en) | 2003-02-03 | 2005-12-21 | Nadkarni, Sunil Sadanand | Process for preparation of clopidogrel, its salts and pharmaceutical compositions |
US6858734B2 (en) * | 2003-04-23 | 2005-02-22 | Rhodia Pharma Solutions Inc. | Preparation of (S)-Clopidogrel and related compounds |
KR100553398B1 (ko) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-c]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
KR100681512B1 (ko) | 2005-03-08 | 2007-02-09 | 주식회사 한서켐 | 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법 |
KR100678287B1 (ko) | 2005-06-23 | 2007-02-02 | 한미약품 주식회사 | 클로피도그렐의 제조방법 및 이에 사용되는 중간체 |
KR101235117B1 (ko) | 2005-12-26 | 2013-02-20 | 에스케이케미칼주식회사 | 광학분리에 의한 (s)-(+)-클로피도그렐의 제조방법 |
CN101121720B (zh) * | 2007-09-14 | 2010-05-19 | 南开大学 | 硫酸氢氯吡格雷的制备方法 |
-
2008
- 2008-06-09 KR KR1020080053815A patent/KR100990949B1/ko active IP Right Grant
-
2009
- 2009-06-09 WO PCT/KR2009/003083 patent/WO2009151256A2/ko active Application Filing
- 2009-06-09 US US12/996,733 patent/US20110087028A1/en not_active Abandoned
- 2009-06-09 JP JP2011512392A patent/JP2011522535A/ja active Pending
- 2009-06-09 RU RU2010154156/04A patent/RU2469039C2/ru not_active IP Right Cessation
- 2009-06-09 CN CN2009801215031A patent/CN102056931A/zh active Pending
- 2009-06-09 EP EP09762643A patent/EP2298777A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495691B1 (en) * | 2001-07-06 | 2002-12-17 | Brantford Chemicals Inc. | Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
US20040176637A1 (en) * | 2003-03-03 | 2004-09-09 | Robert C. C. Wu | Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation |
US20070225320A1 (en) * | 2006-03-27 | 2007-09-27 | Eswaraiah Sajja | Process for preparing clopidogrel |
Non-Patent Citations (1)
Title |
---|
CLINTON A. KRUEGER ET AL.: "Ti-catalyzed enantioselective addition of cyanide to imines. A practical synthesis of optically pure a-amino acids", JOURNAL OF AMERICAN CHEMICAL SOCIETY, vol. 121, 1999, pages 4284 - 4285, XP002131541 * |
Also Published As
Publication number | Publication date |
---|---|
KR20090127714A (ko) | 2009-12-14 |
RU2010154156A (ru) | 2012-07-20 |
EP2298777A4 (en) | 2012-03-14 |
CN102056931A (zh) | 2011-05-11 |
JP2011522535A (ja) | 2011-08-04 |
RU2469039C2 (ru) | 2012-12-10 |
EP2298777A2 (en) | 2011-03-23 |
US20110087028A1 (en) | 2011-04-14 |
KR100990949B1 (ko) | 2010-10-29 |
WO2009151256A2 (ko) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009151256A3 (ko) | 클로피도크렐 및 그의 유도체의 제조방법 | |
WO2008024716A3 (en) | Process of making alkyl esters of free fatty acids | |
WO2014072785A8 (en) | A process for the preparation of pregabalin | |
WO2011127409A3 (en) | Methods and compositions related to fatty alcohol biosynthetic enzymes | |
UA102574C2 (ru) | 1-фенил-2-пиридинилалкил-спиртовые производные как ингибиторы фосфодиэстеразы | |
WO2009061740A3 (en) | Process of producing ethanol using cellulose with enzymes generated through solid state culture | |
WO2012090124A3 (en) | IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF | |
DK1877384T3 (da) | Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer | |
WO2012103279A3 (en) | Methods and compositions for the synthesis of multimerizing agents | |
EA200870581A1 (ru) | Способ превращения нитрильных соединений в карбоновые кислоты и соответствующие эфиры | |
ATE420196T1 (de) | Enzymatische herstellung von degummierten fettsäurealkylestern | |
EA201001671A1 (ru) | Способ стереоселективного ферментативного гидролиза эфира 5-метил-3-нитрометилгексановой кислоты | |
WO2012031045A3 (en) | Phosphonate ester derivatives and methods of synthesis thereof | |
WO2011087316A3 (ko) | 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물 | |
MY151183A (en) | Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof | |
NZ615953A (en) | Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives | |
AU2019268208A1 (en) | Compounds and methods relating to testing for lysosomal storage disorders | |
RS54463B1 (en) | PROCEDURE FOR PREPARING NEBIVOLOL | |
BR112014014762A2 (ko) | A method of producing a cysteine or derivatives thereof using the novel phosphine O- porcelain seolpeu Hyde Lila Ajay | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
WO2006069113A3 (en) | Method to produce a carboxylic acid ester from a carboxylic acid ammonium salt by alcoholysis | |
MX2012001064A (es) | Inhibidores de la fosfolipasa d selectivos de isoforma. | |
WO2006076565A3 (en) | Preparation of chiral propargylic alcohol and ester intermediates of himbacine analogs | |
NZ598278A (en) | Process for preparing biphenyl imidazole compounds | |
WO2008110706A3 (fr) | Procede d'hydrolyse enzymatique chimioselectif d'un compose diester pour la preparation d'un compose monoester monoacide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980121503.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09762643 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011512392 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12996733 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009762643 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2687/MUMNP/2010 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010154156 Country of ref document: RU |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI0909870 Country of ref document: BR Free format text: IDENTIFIQUE O SIGNATARIO DA PETICAO NO018100046476 DE 07/12/2010 E COMPROVE, SE FOR O CASO, QUE O MESMO TEM PODERES PARA ATUAR EM NOME DO DEPOSITANTE, UMA VEZ QUE BASEADO NO ARTIGO 216 DA LEI 9.279/1996 DE 14/05/1996 (LPI) "OS ATOS PREVISTOS NESTA LEI SERAO PRATICADOS PELAS PARTES OU POR SEUS PROCURADORES, DEVIDAMENTE QUALIFICADOS.". |
|
ENPW | Started to enter national phase and was withdrawn or failed for other reasons |
Ref document number: PI0909870 Country of ref document: BR |